Dietary Protein Sources and Glycemic Variability

NCT ID: NCT06525441

Last Updated: 2024-07-31

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

NOT_YET_RECRUITING

Clinical Phase

NA

Total Enrollment

96 participants

Study Classification

INTERVENTIONAL

Study Start Date

2024-08-01

Study Completion Date

2025-02-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This goal of trial is to evaluate the effects of plant-based vs. animal-based diets on glycemic variability in overweight or obese adults through a 3-week dietary intervention.

The main question it aims to answer is:

Will a plant-based diet be able to reduce glycemic variability in overweight or obese adults compared with an animal-based diet?

Participants will strictly follow a designated plant-based or animal-based dietary regimen throughout the duration of the 3-week study. They will wear a Continuous Glucose Monitor (CGM) throughout the study, engage in weekly clinical assessments, and record their daily dietary intake.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Diabetes stands as one of the most rapidly escalating health challenges of the 21st century. Type 2 diabetes, which represents over 90% of all diagnosed cases, is the predominant form of the disease, with obesity and being overweight identified as key risk factors. The mainstay of prevention and management for Type 2 diabetes continues to be dietary intervention and nutritional therapy. Current dietary strategies for Type 2 diabetes focus predominantly on the regulation of fat and carbohydrate intake, while the influence and underlying mechanisms of dietary protein on glucose metabolism are not yet fully comprehended.

A randomized, open-label, parallel-controlled clinical trial, by strictly controlling the source of protein, will be performed to evaluate the effects of a plant-based diet on glycemic variability and other metabolic outcomes in individuals who are overweight or obese, in comparison to an animal-based diet. Eligible participants will be randomly allocated in a 1:1 ratio to either the plant-based or animal-based diet group for a 3-week intervention.

During the intervention, participants in the plant-based diet group will receive three daily meals for three weeks.Of the energy of each meal, 60% is from carbohydrates, 15% from plant protein, and 25% from fat. The primary sources of plant protein will include soybeans, lentils, nuts, grains, and seaweed. Conversely, the animal-based diet group will also be provided with three daily meals for three weeks, with the same caloric distribution, but sourcing their protein from animal products such as poultry, beef, pork, fish, eggs, and dairy.

Participants are required to cooperate in completing the following tasks:

1. Daily dietary record: Participants are to meticulously track their daily food consumption.
2. Continuous 24-hour glucose monitoring and data logging: Subjects are to undergo continuous monitoring of blood glucose levels throughout a 24-hour period, with all data accurately recorded.
3. Physical examination: This will include assessments of height, weight, waist-to-hip circumference ratio, blood pressure, and body composition.
4. Biological sample collection: Samples to be collected include blood, urine, and stool.

The timing for physical examinations and biological sample collections is scheduled as follows: Day 5 ± 2 of the introduction phase, Week 1 ± 2 days of the intervention phase, Week 2 ± 2 days of the intervention phase, and Week 3 ± 2 days of the intervention phase.

Dietary and health counseling will be consistently available throughout the study to provide participants with continuous support and guidance.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Metabolic Disease Diabetes Overweight Obesity Dietary Protein

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

PREVENTION

Blinding Strategy

SINGLE

Outcome Assessors
This trial is an open-label study. Given that dietary intervention will be administered to all participants, it is challenging to implement blinding for the participants. However, throughout the study, the individuals involved in the preparation and distribution of meals, along with those conducting the statistical analysis, will remain blind to the group assignments of the participants.

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Plant-based diet

Participants assigned to the plant-based diet group will be provided three meals daily for 3 weeks. Of the energy of each meal, 60% is from carbohydrates, 15% from plant protein, and 25% from fat. The main dietary sources of plant protein will be soybeans, flat beans, nuts, grains, and algae.

Group Type EXPERIMENTAL

Plant-based Diet

Intervention Type OTHER

Participants assigned to the plant-based diet group will be provided three meals daily for 3 weeks. Of the energy of each meal, 60% is from carbohydrates, 15% from plant protein, and 25% from fat. The main dietary sources of plant protein will be soybeans, flat beans, nuts, grains, and algae.

Animal-based diet

Participants assigned to the animal-based diet group will be provided three meals daily for 3 weeks. Of the energy of each meal, 60% is from carbohydrates, 15% from animal protein, and 25% from fat. The main dietary sources of animal protein will be chicken, beef, pork, fish, eggs, and dairy products.

Group Type ACTIVE_COMPARATOR

Animal-based Diet

Intervention Type OTHER

Participants assigned to the animal-based diet group will be provided three meals daily for 3 weeks. Of the energy of each meal, 60% is from carbohydrates, 15% from animal protein, and 25% from fat. The main dietary sources of animal protein will be chicken, beef, pork, fish, eggs, and dairy products.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Plant-based Diet

Participants assigned to the plant-based diet group will be provided three meals daily for 3 weeks. Of the energy of each meal, 60% is from carbohydrates, 15% from plant protein, and 25% from fat. The main dietary sources of plant protein will be soybeans, flat beans, nuts, grains, and algae.

Intervention Type OTHER

Animal-based Diet

Participants assigned to the animal-based diet group will be provided three meals daily for 3 weeks. Of the energy of each meal, 60% is from carbohydrates, 15% from animal protein, and 25% from fat. The main dietary sources of animal protein will be chicken, beef, pork, fish, eggs, and dairy products.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. Men or women aged 20-65 years.
2. Body Mass Index (BMI) greater than 25kg/m2.
3. Capable of using a smartphone application daily for taking photos and recording dietary intake.
4. Maintained stable body weight over the past three months with a regular routine.
5. Possess self-care ability for independent living.
6. Not currently participating in any other clinical research projects.
7. Signed the informed consent form and willing to adhere to and complete the entire research process.

Exclusion Criteria

1. With diagnosed diabetes.
2. With severe cardiovascular or cerebrovascular diseases (e.g., angina, myocardial infarction, or stroke) or cancer.
3. Taking medications affecting weight or energy intake/energy expenditure in the last 3 months, including weight loss medications, antipsychotic drugs or other medications as determined by the study physician.
4. Participating in weight loss treatments.
5. History of severe gastrointestinal diseases or gastrointestinal surgery within the past 12 months.
6. Those with allergic reactions to common foods (for example, eggs, nuts, grains) or those who are lactose intolerant.
7. Women who are pregnant or plan to become pregnant.
8. Diagnosis of HIV, hepatitis B or C, or active tuberculosis.
9. Special groups who are specifically unsuitable for a diet consisting of whole plant proteins.
10. Patients who are unwilling or unable to give informed consent.
Minimum Eligible Age

20 Years

Maximum Eligible Age

65 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Guangdong Provincial People's Hospital

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Jie Li

Professor, Deputy director of global health research center

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Jie Li

Role: PRINCIPAL_INVESTIGATOR

Guangdong Provincial People's Hospital

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Juncheng Zhuang

Role: CONTACT

+86-020-33971424

Jie Li

Role: CONTACT

+86-020-33971424

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

KY2024-501-03

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.